Miller Howard Investments Inc. NY grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 19.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,941 shares of the company’s stock after purchasing an additional 1,800 shares during the quarter. Miller Howard Investments Inc. NY’s holdings in HCA Healthcare were worth $4,669,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also modified their holdings of the stock. Cedar Mountain Advisors LLC acquired a new position in HCA Healthcare in the first quarter valued at $33,000. MidFirst Bank purchased a new position in shares of HCA Healthcare during the second quarter worth about $28,000. Clearstead Trust LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth about $29,000. Delos Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth about $35,000. Finally, SJS Investment Consulting Inc. lifted its holdings in shares of HCA Healthcare by 73.1% in the 1st quarter. SJS Investment Consulting Inc. now owns 90 shares of the company’s stock valued at $43,000 after purchasing an additional 38 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Analyst Upgrades and Downgrades
HCA has been the subject of a number of research analyst reports. BMO Capital Markets started coverage on HCA Healthcare in a research report on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 target price for the company. Leerink Partners reaffirmed an “outperform” rating and set a $492.00 price target on shares of HCA Healthcare in a research report on Friday, September 18th. Jefferies Financial Group set a $450.00 price objective on HCA Healthcare in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a research report on Monday, July 27th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a report on Friday, October 2nd. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $467.50.
View Our Latest Stock Report on HCA Healthcare
HCA Healthcare Trading Down 1.0%
NYSE HCA opened at $464.45 on Tuesday. The business’s 50 day moving average is $431.57 and its two-hundred day moving average is $445.15. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The stock has a market capitalization of $100.55 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 1.58 and a beta of 1.10.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the prior year, the business posted $6.84 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities analysts forecast that HCA Healthcare, Inc. will post 29.51 earnings per share for the current fiscal year.
HCA Healthcare Profile
HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.
The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
